Loss of kidney function in older people with HIV underlines need for earlier treatment
HIV/HCV co-infected people can do well on hepatitis C triple therapy despite contraindications
Genetic testing lowers risk of nevirapine skin rash
Vaccination could prevent infection with anal cancer-associated HPV strains in older gay men
Male circumcision: the message is catching on, but scale-up poses monitoring and follow-up problems
Text messages to mothers improve early infant HIV diagnosis rates in Kenya and Mozambique
'Option B+' women are at increased risk of loss to follow-up after starting HIV treatment
Kidney problems linked to tenofovir use, improve with switch to abacavir
Stigma, delay and misunderstanding slow access to ART in Africa
Scientists and clinicians must challenge HIV-related stigma and ensure enabling legal and policy environments, IAS conference hears
Efavirenz in children: WHO dosing guidelines raise the risk of side-effects in Thai children
Non-African middle-income countries pay four times more for ARVs than African middle-income countries
Darunavir/ritonavir safe and effective for younger children
Lower-dose lopinavir/ritonavir reduces side-effects, maintains viral control in Thai children
Magical thinking? FEM-PrEP trial may have failed because participants used testing as prevention
Malaysia’s harm reduction programmes are preventing infections and saving money, but reaching far too few people who inject drugs
Fibroscan accurately predicts liver decompensation and death in HIV/HCV co-infected people
Studies look at bone changes during second-line therapy, fractures, and HIV- and HCV-related bone loss
